Cebix Incorporated Inks $30.9m Series C and Appoints President and CEO

Cebix Incorporated, a biopharmaceutical company developing treatments for complications of diabetes, has secured a $30.9M Series B investment. Prior investors InterWest, Sofinnova Ventures and Thomas, McNerney & Partners all participated in the financing. The company has also appointed Dr. Joel Martin as president and CEO.

peHUB First Read

Everyone, please meet Radish the cat, peHUB’s new intern. We’re still training her to fetch coffee. Or, anything.

Alimera Sciences Inks $40m Series A led by Palo Alto Investors

Alimera Sciences, a biopharmaceutical company specialising in the research, development and commercialization of prescription ophthalmic pharmaceuticals, has secured a $40 million Series A financing. Palo Alto Investors acted as the lead investor in the offering, with Sofinnova Ventures and New Enterprise Associates also participating. PRESS RELEASE Alimera Sciences, Inc., (Nasdaq:ALIM) (Alimera), a biopharmaceutical company that […]

Catalyst Biosciences Inks $7M from Phizer

Catalyst Biosciences Inc. has sealed a $7 million milestone payment from Pfizer, as part of a research and license agreement between the two companies. Catalyst recently initiated Phase 1 clinical trials for one of its products, designed to help treat hemophilia patients. Privately held Catalyst is backed by investors including Essex Woodlands Health Ventures, HealthCare Ventures, Johnson & Johnson Development Corporation, Morgenthaler Ventures, Novartis BioVentures, RCT BioVentures and Sofinnova Ventures.

Takeda Pharmaceutical Buys VC-Backed Intellikine

Takeda Pharmaceutical Company, a listed, Japanese pharmaceutical research company, is buying venture-backed Intellikine Inc. Takeda will pay $190 million in cash, and up to $120 million in additional milestone payments. Intellikine was backed by at least $41 million from venture investors including Abingworth, BiogenIdec, CMEA Capital, Fintech Global Capital, Novartis Venture Funds, Sofinnova Ventures and U.S. Venture Partners.

peHUB First Read

Cowa-Bunga-Bunga: Berlusconi’s outta here!

L’Chaim! Sofinnova Ventures eyes Israel

Back in Action: SAC Capital spinoff Siris

They’ll be Back: Occupy Zuccotti protestors plot NY-to-DC march

Me, Too! Now Yelp wants to go public

Fund Founded: Thiel’s fund said to be raising up to $600 million

Stashing the Cash: JC Flowers weathers global market turmoil

Cloud’s Silver Lining: start-up rolls out new product and boosts management team

Bring it Back: Back9 boosts funding round

A Healthy Start: Healthcare resource start-up Kyruus raises $3 million

Intellikine Adds $4M in Milestone Payments

Biopharma company Intellikine Inc. has sealed $4 million in new milestone payments as it begins two Phase 1 clinical trials of its drugs. The company, based in La Jolla, Calif., is backed by $41 million from venture investors including Abingworth, BiogenIdec, CMEA Capital, Fintech Global Capital, Novartis Venture Funds, Sofinnova Ventures and U.S. Venture Partners.

Sofinnova Closes $440M Eighth Fund

Sofinnova Ventures has closed its eighth fund, Sofinnova Venture Partners VIII, with a total of $440 million in commitments and a sharpened focus on clinical-stage drug companies. The firm began fundraising in February, and held a first close four months later, says general partner Garheng Kong. Unlike the firm’s previous fund, which included investments in […]

Mobile Ad Firm Blyk Names Insider Eric Kip as CEO

Blyk, a mobile ad firm, has promoted chief commercial officer Eric Kip to the post of chief executive, replacing Blyk cofounder Pekka Ala-Pietila. Blyk, which has offices in Helsinki, London, Amsterdam, and Delhi, has raised €87M since its 2006 founding, including from Sofinnova Ventures, Goldman Sachs, and Nexit Ventures. REUTERS: Blyk, a pioneer in the mobile-telephone advertising business, said […]

Allergan Buys Vicept Therapeutics

Allergan is buying privately held dermatology company Vicept Therapeutics. Formed in 2009, Vicept is backed by investors including Vivo Ventures, Fidelity Biosciences and Sofinnova Ventures. Under the terms of the acquisition, which is expected to close during the third quarter, Allergan will pay $75 million in cash up-front, as well as up to $200 million in payments tied to specific milestones.

SARcode Bioscience Inks $44M Series B

Brisbane, Calif.-based SARcode Bioscience has closed on $44 million in Series B financing, led by Sofinnova Ventures. Rho Ventures also participated, as did existing investors Alta Partners and Clarus Venture Partners. The money will go toward clinical development of the company’s treatment for dry eye syndrome.

Sorbent Therapeutics Soaks Up $36M Series B

Sorbent Therapeutics, the California-based biopharmaceutical company, took $36 million from a group of VCs, the company announced. Investors include Novartis Venture Funds, which led the financing, joining existing investors Sofinnova Ventures, ARCH Venture Partners, CMEA Capital and AgeChem. The deal brings Sorbent’s total funding to $53 million.

Aerie Pharmaceuticals Closes $30M Series B

Aerie Pharmaceuticals Inc., a biotechnology company focused on medical innovations in ophthalmology, has closed $30 million in Series B financing. Clarus Ventures and Sofinnova Ventures co-led the round, with participation from Osage University Partners and existing investors Alta Partners and TPG Biotech. Aerie Pharmaceuticals has offices in Research Triangle Park, N.C. and in Bridgewater, N.J.

George Horner Joins Sofinnova Ventures

George Horner has joined Sofinnova Ventures as an executive-in-residence, according to VentureWire. He is the former CEO of Prestwick Pharmaceuticals, a Sofinnova-backed company sold last year to Biovail Corp. for $100 million in cash.

PEHUB Community

Join the 12501 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

PE HUB News Briefs

RSS Feed Widget


VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget